Woodline Partners’s Silence Therapeutics SLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $362K | Sell |
62,459
-72,033
| -54% | -$418K | ﹤0.01% | 878 |
|
|
2025
Q1 | $379K | Sell |
134,492
-364,240
| -73% | -$1.03M | ﹤0.01% | 842 |
|
|
2024
Q4 | $3.43M | Buy |
498,732
+91,829
| +23% | +$632K | 0.02% | 560 |
|
|
2024
Q3 | $7.4M | Buy |
406,903
+316,041
| +348% | +$5.75M | 0.06% | 337 |
|
|
2024
Q2 | $1.73M | Sell |
90,862
-147,518
| -62% | -$2.8M | 0.02% | 430 |
|
|
2024
Q1 | $5.15M | Buy |
238,380
+189,108
| +384% | +$4.08M | 0.05% | 354 |
|
|
2023
Q4 | $856K | Sell |
49,272
-117,380
| -70% | -$2.04M | 0.01% | 409 |
|
|
2023
Q3 | $1.64M | Sell |
166,652
-72,708
| -30% | -$714K | 0.02% | 414 |
|
|
2023
Q2 | $1.32M | Buy |
239,360
+95,676
| +67% | +$526K | 0.02% | 463 |
|
|
2023
Q1 | $891K | Buy |
143,684
+20,643
| +17% | +$128K | 0.01% | 481 |
|
|
2022
Q4 | $1.88M | Buy |
123,041
+7,921
| +7% | +$121K | 0.03% | 488 |
|
|
2022
Q3 | $1.16M | Buy |
+115,120
| New | +$1.16M | 0.02% | 523 |
|